期刊文献+

辛伐他汀治疗早期糖尿病肾脏疾病疗效观察

下载PDF
导出
摘要 目的:观察辛伐他汀治疗早期糖尿病肾病患者尿蛋白及血脂等改变。方法:将确诊的早期糖尿病肾病患者60例随机分成对照组30例和治疗组30例,治疗前均检测血糖、血脂、尿白蛋白等指标。对照组给予降糖、降压等常规治疗;治疗组除常规治疗外,增加辛伐他汀20mg,口服,每晚1次。治疗半年年后,均再次检测上述指标,对比其两组治疗前后的变化。结果:治疗组总有效率达93.3%,对照组达66.67%。结论:辛伐他汀能减少早期糖尿病肾病患者尿蛋白,且独立于其调脂效应外,延缓糖尿病肾病的进展。
出处 《包头医学》 2012年第2期79-80,共2页 Journal of Baotou Medicine
  • 相关文献

参考文献3

  • 1Yang WY,LU JM,Wang JP,et al.prevalence of Diabetes among me and women in China[J].N Eng J Med,2010,362:1090-1101.
  • 2陶建瓴,李学旺.慢性肾脏病脂质异常的治疗及意义[J].中国实用内科杂志,2010,30(10):872-874. 被引量:11
  • 3Joslin,潘长玉主译.糖尿病学[M].第14版.北京:人民卫生出版社,2007.890-894.

二级参考文献7

  • 1Attrnan PO, Samuelsson O. Dyslipidemia of kidney disease [ J ]. Curt Opin Lipido1,2009 ,20 :293 - 299.
  • 2Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community[ J]. J Am Coll Cardiol ,2003 ,41:47 -55.
  • 3Navaneethan SD, Pansini F, Strippoli GF. Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials [ J ]. PLoS Med,2006,3 : e123.
  • 4Bell S, Deighan CJ. The conundrum of statins in chronic kidney disease[ J ]. Scott Med J ,2010,55:30 - 33.
  • 5Tonelli M, Moye L, Sacks FM, et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease [ J ]. J Am Soc Nephrol, 2003, 14: 1605 - 1613.
  • 6Navaneethan SD,Pansini F,Perkovic V,et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis [ J ]. Cochrane Database Syst Rev, 2009, ( 2 ) : CD007784.
  • 7Lewis D,Haynes R, Landray MJ. Lipids in chronic kidney disease [J]. J Ren Care,2010,36,S1:27 -33.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部